ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Kitov Pharamceuticals Holdings Ltd
4.17
0.0000
成交量:
- -
成交額:
- -
市值:
7,176.81萬
市盈率:
-0.53
高:
4.17
開:
4.17
低:
4.17
收:
4.17
52周最高:
14.40
52周最低:
2.20
股本:
1,721.06萬
流通股本:
1,687.03萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-7.7983
每股收益(LYR):
-3.0205
淨資產收益率:
-92.04%
總資產收益率:
-9.15%
市淨率:
1.29
市盈率(LYR):
-1.38
資料載入中...
總覽
公司
新聞資訊
公告
2020/05/20
SEC問詢函
CORRESP [Cover] - Correspondence
2020/05/18
員工持股計劃
S-8 - Securities to be offered to employees in employee benefit plans
2020/05/15
超過5%披露
SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/06
超過5%披露
Statement of acquisition of beneficial ownership by individuals
2020/03/31
[修訂]年度報告
[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/23
年度報告
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/23
超過5%披露
Statement of acquisition of beneficial ownership by individuals
2020/03/20
超過5%披露
SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/17
非美公司披露報告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13
非美公司披露報告
6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11
[修訂]招股説明書
F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/03/10
SEC問詢函
CORRESP [Cover] - Correspondence
2020/03/10
SEC問詢函
CORRESP [Cover] - Correspondence
2020/03/10
[修訂]招股説明書
[Amend] Registration statement for certain foreign private issuers
2020/02/24
非美公司披露報告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13
超過5%披露
Statement of acquisition of beneficial ownership by individuals
2020/02/11
非美公司披露報告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/03
非美公司披露報告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/27
非美公司披露報告
Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/15
超過5%披露
[Amend] Statement of acquisition of beneficial ownership by individuals
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/KTOV/filings"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KTOV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KTOV\",,,,,undefined,":{"symbol":"KTOV","market":"US","secType":"STK","nameCN":"Kitov Pharamceuticals Holdings Ltd","latestPrice":4.17,"timestamp":1608584400000,"preClose":4.17,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":16870285,"shares":17210574,"eps":-7.79832,"marketStatus":"未開盤","change":0,"latestTime":"12-21 16:00:00 EST","open":4.17,"high":4.17,"low":4.17,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.79832,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1771578000000},"marketStatusCode":0,"symbolChange":{"newSymbol":"PPBT","executeDate":"2020-12-22"},"adr":0,"adrRate":10,"listingDate":1447995600000,"exchange":"NASDAQ","adjPreClose":4.17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KTOV\",,,,,undefined,":{"symbol":"KTOV","floatShares":16870285,"roa":"-9.15%","roe":"-92.04%","lyrEps":-3.02052,"shares":17210574,"dividePrice":0,"high":4.17,"amplitude":0,"preClose":4.17,"low":4.17,"week52Low":2.2,"pbRate":"1.29","week52High":14.4,"institutionHeld":0,"latestPrice":4.17,"eps":-7.79832,"divideRate":0,"volume":0,"delay":0,"ttmEps":-7.79832,"open":4.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KTOV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-12-22","symbol":"KTOV","oldSymbol":"KTOV","defaultRemindTime":1608647400000,"newSymbol":"PPBT","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1608613200000},{"market":"US","date":"2020-08-21","symbol":"KTOV","defaultRemindTime":1598016600000,"type":"split","dateTimestamp":1597982400000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KTOV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KTOV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"KTOV\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"10065563","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020013056-KTOV","pdf_url":null,"pub_time":1589904000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"CORRESP [Cover] - Correspondence","symbol":"KTOV","title":"CORRESP [Cover] - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020013056/0001213900-20-013056-index.htm","us_notice_code":"Form CORRESP","us_title_en":"CORRESP [Cover] - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020013056/filename1.htm","primary":true,"translateUrl":null,"linkName":"filename1.htm","type":"CORRESP","id":"NTFILE9nbmQRuVLRd2ovAZ","market":"us","size":7714}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2020-05-20 00:00","pubTimestamp":1589904000,"title_zh":"CORRESP [Cover] - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9725790","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020012852-KTOV","pdf_url":null,"pub_time":1589731200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8 - Securities to be offered to employees in employee benefit plans","symbol":"KTOV","title":"S-8 - Securities to be offered to employees in employee benefit plans","titleType":"員工持股計劃","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020012852/0001213900-20-012852-index.htm","us_notice_code":"Form S-8","us_title_en":"S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020012852/ea122048-s8_kitovpharma.htm","primary":true,"translateUrl":null,"linkName":"ea122048-s8_kitovpharma.htm","type":"S-8","id":"NTFILEApinmnsMRwYGsHi3","market":"us","size":136474},{"description":"FORM OF OPINION OF THE LAW OFFICE OF AVRAHAM BEN-TZVI, ADV., ISRAELI COUNSEL TO","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020012852/ea122048ex5-1_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ea122048ex5-1_kitovpharma.htm","type":"EX-5.1","id":"NTFILE78JKYENmLg5HemQP","market":"us","size":14143},{"description":"CONSENT OF SOMEKH CHAIKIN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, A MEMB","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020012852/ea122048ex23-2_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ea122048ex23-2_kitovpharma.htm","type":"EX-23.2","id":"NTFILEAKE2YhoUuXWzBRrq","market":"us","size":4382},{"description":"KITOV PHARMA LTD. 2016 EQUITY-BASED INCENTIVE PLAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020012852/ea122048ex99-1_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ea122048ex99-1_kitovpharma.htm","type":"EX-99.1","id":"NTFILEABgd6StTaNvR4bNZ","market":"us","size":145285},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020012852/ex5-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE832WPdWKbcFqkaBH","market":"us","size":52422},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020012852/ex5-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILEF3bEHXYMxDSnAKfw","market":"us","size":46495}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"員工持股計劃","pubTime":"2020-05-18 00:00","pubTimestamp":1589731200,"title_zh":"S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"S-8 - Securities to be offered to employees in employee benefit plans","summary_zh":"S-8-在僱員福利計劃中向僱員提供的證券","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9725789","market":"us","labels":[],"media":"sec.gov","original_id":"AN91957420003730-KTOV","pdf_url":null,"pub_time":1589472000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"KTOV","title":"SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000091957420003730/0000919574-20-003730-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1601086/000091957420003730/d8534443_sc13-g.htm","primary":true,"translateUrl":null,"linkName":"d8534443_sc13-g.htm","type":"SC 13G","id":"NTFILEFdNM8W42GZcRrPwG","market":"us","size":69780}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2020-05-15 00:00","pubTimestamp":1589472000,"title_zh":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_zh":"SC13G-個人取得實益擁有權聲明書","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9684163","market":"us","labels":[],"media":"sec.gov","original_id":"AN153561020000094-KTOV","pdf_url":null,"pub_time":1588694400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Statement of acquisition of beneficial ownership by individuals","symbol":"KTOV","title":"Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000153561020000094/0001535610-20-000094-index.htm","us_notice_code":"Form SC 13G","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SABBY 13G KTOV 5.06.20","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1535610/000153561020000094/ktov0520.txt","primary":true,"translateUrl":null,"linkName":"ktov0520.txt","type":"SC 13G","id":"NTFILE5hTbn4KdurDLV3dE","market":"us","size":11609}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2020-05-06 00:00","pubTimestamp":1588694400,"title_zh":"Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9395540","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020008240-KTOV","pdf_url":null,"pub_time":1585584000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"KTOV","title":"[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"[修訂]年度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/0001213900-20-008240-index.htm","us_notice_code":"Form 20-F/A","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO.1 TO FORM 20-F","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/f20f2019a1_kitovpharma.htm","primary":true,"translateUrl":null,"linkName":"f20f2019a1_kitovpharma.htm","type":"20-F/A","id":"NTFILE5ofGhXNT9fRfHrty","market":"us","size":103742},{"description":"AMENDED AND RESTATED LICENSE EFFECTIVE AS OF THE 25TH DAY OF MAY, 2010 BY AND BE","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/f20f2019a1ex4-23_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019a1ex4-23_kitov.htm","type":"EX-4.23","id":"NTFILEBerxJ8oEGWfdbDNX","market":"us","size":147080},{"description":"FIRST AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT, BY AND BETWEEN TEL HA","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/f20f2019a1ex4-24_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019a1ex4-24_kitov.htm","type":"EX-4.24","id":"NTFILEJ76efyzdtiBnsTXm","market":"us","size":13776},{"description":"SECOND AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT, BY AND BETWEEN TEL H","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/f20f2019a1ex4-25_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019a1ex4-25_kitov.htm","type":"EX-4.25","id":"NTFILE4Zc2odxco5bZeCWb","market":"us","size":21162},{"description":"ASSIGNMENT AND ASSUMPTION AGREEMENT EFFECTIVE AS OF MARCH 21, 2019, BETWEEN TEL","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/f20f2019a1ex4-26_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019a1ex4-26_kitov.htm","type":"EX-4.26","id":"NTFILEAX6hL76g6f3gLetW","market":"us","size":19318},{"description":"MASTER DEVELOPMENT SERVICES AGREEMENT BETWEEN FAMEWAVE LTD., AND RENTSCHLER BIOP","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/f20f2019a1ex4-27_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019a1ex4-27_kitov.htm","type":"EX-4.27","id":"NTFILE5sQK8xNV3DJeGMVx","market":"us","size":299639},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/f20f2019a1ex12-1_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019a1ex12-1_kitov.htm","type":"EX-12.1","id":"NTFILEEvLJAmd7wvpg3ei6","market":"us","size":3289},{"description":"CERTIFICATION","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/f20f2019a1ex12-2_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019a1ex12-2_kitov.htm","type":"EX-12.2","id":"NTFILEG6mD4cVPBtTtJQWV","market":"us","size":3063},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020008240/ex4-27_001.jpg","primary":false,"translateUrl":null,"linkName":"ex4-27_001.jpg","type":"GRAPHIC","id":"NTFILEGfo1TuV8TjjNUsXh","market":"us","size":13504}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Annual Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]年度報告","pubTime":"2020-03-31 00:00","pubTimestamp":1585584000,"title_zh":"Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9216219","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020007156-KTOV","pdf_url":null,"pub_time":1584892800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"KTOV","title":"Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/0001213900-20-007156-index.htm","us_notice_code":"Form 20-F","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNAUL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/f20f2019_kitovpharmaltd.htm","primary":true,"translateUrl":null,"linkName":"f20f2019_kitovpharmaltd.htm","type":"20-F","id":"NTFILEEPEUAxQ1ybhxHanu","market":"us","size":2810242},{"description":"DESCRIPTION OF SHARES CAPITAL","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/f20f2019ex2-21_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex2-21_kitov.htm","type":"EX-2.21","id":"NTFILEDbxeiXJx5giUq3bF","market":"us","size":163040},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/f20f2019ex12-1_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex12-1_kitov.htm","type":"EX-12.1","id":"NTFILEG9kvWbb2CZkKMkT8","market":"us","size":8868},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/f20f2019ex12-2_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex12-2_kitov.htm","type":"EX-12.2","id":"NTFILEDEqm3Qx1Hju8AqPZ","market":"us","size":8772},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/f20f2019ex13-1_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex13-1_kitov.htm","type":"EX-13.1","id":"NTFILEAA11hEhnhes4UCWX","market":"us","size":4300},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/f20f2019ex13-2_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex13-2_kitov.htm","type":"EX-13.2","id":"NTFILE95CV9qDLavwyUQCW","market":"us","size":4310},{"description":"CONSENT OF SOMEKH CHAIKIN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, A MEMB","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/f20f2019ex15-1_kitov.htm","primary":false,"translateUrl":null,"linkName":"f20f2019ex15-1_kitov.htm","type":"EX-15.1","id":"NTFILEBnNi7xkhA8aL4ahg","market":"us","size":3168},{"description":"XBRL INSTANCE FILE","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/ktov-20191231.xml","primary":false,"translateUrl":null,"linkName":"ktov-20191231.xml","type":"EX-101.INS","id":"NTFILEBrjdR88zH4Vb5tvV","market":"us","size":1283188},{"description":"XBRL SCHEMA FILE","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/ktov-20191231.xsd","primary":false,"translateUrl":null,"linkName":"ktov-20191231.xsd","type":"EX-101.SCH","id":"NTFILE68QC8qW5g4iGMppw","market":"us","size":106456},{"description":"XBRL CALCULATION FILE","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/ktov-20191231_cal.xml","primary":false,"translateUrl":null,"linkName":"ktov-20191231_cal.xml","type":"EX-101.CAL","id":"NTFILEF3dKcXnZoJntGFEx","market":"us","size":78663},{"description":"XBRL DEFINITION FILE","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/ktov-20191231_def.xml","primary":false,"translateUrl":null,"linkName":"ktov-20191231_def.xml","type":"EX-101.DEF","id":"NTFILEGn4qXqyJ94DRzTzj","market":"us","size":237522},{"description":"XBRL LABEL FILE","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/ktov-20191231_lab.xml","primary":false,"translateUrl":null,"linkName":"ktov-20191231_lab.xml","type":"EX-101.LAB","id":"NTFILED2thgV6dUnawGS7t","market":"us","size":513075},{"description":"XBRL PRESENTATION FILE","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/ktov-20191231_pre.xml","primary":false,"translateUrl":null,"linkName":"ktov-20191231_pre.xml","type":"EX-101.PRE","id":"NTFILECUihjGQgJ8ZPxsxN","market":"us","size":375948},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE55jss78STTopAusv","market":"us","size":12051},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/image_002.jpg","primary":false,"translateUrl":null,"linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILEHiycE7n8ZoRbyCFF","market":"us","size":21548},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/image_003.jpg","primary":false,"translateUrl":null,"linkName":"image_003.jpg","type":"GRAPHIC","id":"NTFILE4vd7UXnn6YdFaZ98","market":"us","size":8932}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[],"event_type":"important_notice","event_name":"年度報告","pubTime":"2020-03-23 00:00","pubTimestamp":1584892800,"title_zh":"Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9216184","market":"us","labels":[],"media":"sec.gov","original_id":"AN91957420002544-KTOV","pdf_url":null,"pub_time":1584892800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Statement of acquisition of beneficial ownership by individuals","symbol":"KTOV","title":"Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000091957420002544/0000919574-20-002544-index.htm","us_notice_code":"Form SC 13G","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1601086/000091957420002544/d8497889_sc13-g.htm","primary":true,"translateUrl":null,"linkName":"d8497889_sc13-g.htm","type":"SC 13G","id":"NTFILE5EDfw6mU9heU7sdJ","market":"us","size":72492}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2020-03-23 00:00","pubTimestamp":1584892800,"title_zh":"Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9210534","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465920036510-KTOV","pdf_url":null,"pub_time":1584633600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"KTOV","title":"SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000110465920036510/0001104659-20-036510-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000110465920036510/a20-13279_1sc13g.htm","primary":true,"translateUrl":null,"linkName":"a20-13279_1sc13g.htm","type":"SC 13G","id":"NTFILEBEMV9u97oTAyNGwB","market":"us","size":98599}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2020-03-20 00:00","pubTimestamp":1584633600,"title_zh":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9192821","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020006622-KTOV","pdf_url":null,"pub_time":1584374400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"KTOV","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露報告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020006622/0001213900-20-006622-index.htm","us_notice_code":"Form 6-K","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE-CLOSING OF PUBLIC OFFERING","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020006622/ea119698ex99-1_kitovpharma.htm","primary":true,"translateUrl":null,"linkName":"ea119698ex99-1_kitovpharma.htm","type":"EX-99.1","id":"NTFILE7duHbupBXeERHVqJ","market":"us","size":12034},{"description":"FORM 6-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020006622/ea119698-6k_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ea119698-6k_kitovpharma.htm","type":"6-K","id":"NTFILE6EqxBQdz6jmh3MNi","market":"us","size":11415}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露報告","pubTime":"2020-03-17 00:00","pubTimestamp":1584374400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9185187","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020006169-KTOV","pdf_url":null,"pub_time":1584028800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"KTOV","title":"6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露報告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020006169/0001213900-20-006169-index.htm","us_notice_code":"Form 6-K","us_title_en":"6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE PRICING OF PUBLIC OFFERING","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020006169/ea119580ex991_kitovpharma.htm","primary":true,"translateUrl":null,"linkName":"ea119580ex991_kitovpharma.htm","type":"EX-99.1","id":"NTFILE9sjRQ3bM5W3edMXJ","market":"us","size":14032},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020006169/ea119580-6k_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ea119580-6k_kitovpharma.htm","type":"6-K","id":"NTFILE9rY2NWxZvSGkSsUF","market":"us","size":14373},{"description":"PRESS RELEASE UPDATE ON U.S. LAUNCH OF CONSENSI","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020006169/ea119580ex992_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ea119580ex992_kitovpharma.htm","type":"EX-99.2","id":"NTFILEHRc74keHeqYzJ58X","market":"us","size":54403}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露報告","pubTime":"2020-03-13 00:00","pubTimestamp":1584028800,"title_zh":"6-K - Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9178215","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020005946-KTOV","pdf_url":null,"pub_time":1583856000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"F-1/A [Amend] - Registration statement for certain foreign private issuers","symbol":"KTOV","title":"F-1/A [Amend] - Registration statement for certain foreign private issuers","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005946/0001213900-20-005946-index.htm","us_notice_code":"Form F-1/A","us_title_en":"F-1/A [Amend] - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 2 TO REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005946/ff12019a2_kitovpharma.htm","primary":true,"translateUrl":null,"linkName":"ff12019a2_kitovpharma.htm","type":"F-1/A","id":"NTFILE9niJ1d6jLFbr2C68","market":"us","size":987269},{"description":"CONSENT OF SOMEKH CHAIKIN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, A MEMB","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005946/ff12019a2ex23-3_kitov.htm","primary":false,"translateUrl":null,"linkName":"ff12019a2ex23-3_kitov.htm","type":"EX-23.3","id":"NTFILE7daAu5RkCkgp9UrT","market":"us","size":3092},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005946/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILE5nB43D8XeXoaUVfa","market":"us","size":12912},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005946/img_002.jpg","primary":false,"translateUrl":null,"linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILEH61317tbXzsZeXU7","market":"us","size":12912}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2020-03-11 00:00","pubTimestamp":1583856000,"title_zh":"F-1/A [Amend] - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9429509","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020005823-KTOV","pdf_url":null,"pub_time":1583769600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"CORRESP [Cover] - Correspondence","symbol":"KTOV","title":"CORRESP [Cover] - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005823/0001213900-20-005823-index.htm","us_notice_code":"Form CORRESP","us_title_en":"CORRESP [Cover] - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005823/filename1.htm","primary":true,"translateUrl":null,"linkName":"filename1.htm","type":"CORRESP","id":"NTFILEDoVjqDsFr3ooUfuQ","market":"us","size":5453}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2020-03-10 00:00","pubTimestamp":1583769600,"title_zh":"CORRESP [Cover] - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9429508","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020005825-KTOV","pdf_url":null,"pub_time":1583769600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"CORRESP [Cover] - Correspondence","symbol":"KTOV","title":"CORRESP [Cover] - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005825/0001213900-20-005825-index.htm","us_notice_code":"Form CORRESP","us_title_en":"CORRESP [Cover] - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005825/filename1.htm","primary":true,"translateUrl":null,"linkName":"filename1.htm","type":"CORRESP","id":"NTFILEGnHnUn2k7cbb16yW","market":"us","size":6914}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2020-03-10 00:00","pubTimestamp":1583769600,"title_zh":"CORRESP [Cover] - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9173549","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020005814-KTOV","pdf_url":null,"pub_time":1583769600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] Registration statement for certain foreign private issuers","symbol":"KTOV","title":"[Amend] Registration statement for certain foreign private issuers","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/0001213900-20-005814-index.htm","us_notice_code":"Form F-1/A","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM F-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1_kitovpharma.htm","primary":true,"translateUrl":null,"linkName":"ff12019a1_kitovpharma.htm","type":"F-1/A","id":"NTFILEAQuy5Y89ZQd4Q7sB","market":"us","size":857122},{"description":"FORM OF SHAREHOLDER UNDERTAKING AND AGREEMENT, DATED JANUARY 7, 2020, BETWEEN KI","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex4-17_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ff12019a1ex4-17_kitovpharma.htm","type":"EX-4.17","id":"NTFILE7WdpEEjKYWzwhu5U","market":"us","size":106578},{"description":"FORM OF WARRANT ISSUED IN FAMEWAVE TRANSACTION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex4-18_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ff12019a1ex4-18_kitovpharma.htm","type":"EX-4.18","id":"NTFILEBvdNFupSwCDFK3ge","market":"us","size":67571},{"description":"FORM OF ORDINARY WARRANT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex4-19_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ff12019a1ex4-19_kitovpharma.htm","type":"EX-4.19","id":"NTFILE2WaofdJ1jUAqHU21","market":"us","size":102642},{"description":"FORM OF PRE-FUNDED WARRANT","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex4-20_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ff12019a1ex4-20_kitovpharma.htm","type":"EX-4.20","id":"NTFILE3st3nXxSo77DZ5pa","market":"us","size":131467},{"description":"FORM OF PLACEMENT AGENT WARRANT","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex4-21_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ff12019a1ex4-21_kitovpharma.htm","type":"EX-4.21","id":"NTFILECnNcQgwViGwc2coY","market":"us","size":109063},{"description":"OPINION OF LAW OFFICE OF AVRAHAM BEN-TZVI, ADV","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex5-1_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ff12019a1ex5-1_kitovpharma.htm","type":"EX-5.1","id":"NTFILEGFtuTJf6H4G6VQWz","market":"us","size":20331},{"description":"OPINION OF HAYNES AND BOONE LLP, U.S. LEGAL COUNSEL TO THE REGISTRANT","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex5-2_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ff12019a1ex5-2_kitovpharma.htm","type":"EX-5.2","id":"NTFILECfnYCULYYeCHYfP1","market":"us","size":12301},{"description":"FORM OF SECURITIES PURCHASE AGREEMENT","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex10-21_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ff12019a1ex10-21_kitovpharma.htm","type":"EX-10.21","id":"NTFILED1PxNVHf839ijxVw","market":"us","size":256349},{"description":"FORM OF LOCK-UP AND REGISTRATION RIGHTS AGREEMENT, DATED JANUARY 7, 2020, BETWEE","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex10-22_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ff12019a1ex10-22_kitovpharma.htm","type":"EX-10.22","id":"NTFILEABpkFEyn2vqXD39d","market":"us","size":109754},{"description":"LIST OF SUBSIDIARIES OF THE REGISTRANT","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex21-1_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ff12019a1ex21-1_kitovpharma.htm","type":"EX-21.1","id":"NTFILE9bWgYvLMvJ7PjxrK","market":"us","size":4755},{"description":"CONSENT OF SOMEKH CHAIKIN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, A MEMB","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ff12019a1ex23-3_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"ff12019a1ex23-3_kitovpharma.htm","type":"EX-23.3","id":"NTFILE2jv65szBt1bsfYcH","market":"us","size":5032},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILEAoSWrpgkeMMayZeF","market":"us","size":12912},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ex5-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE2D6Mn4uFUEpfQ4Kv","market":"us","size":65270},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/ex5-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILE3QYpTYN13dk4xR5Y","market":"us","size":55275},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020005814/img_002.jpg","primary":false,"translateUrl":null,"linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILE2HzZpoj8UrbM4gVj","market":"us","size":12912}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2020-03-10 00:00","pubTimestamp":1583769600,"title_zh":"Amend] Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9125630","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020004575-KTOV","pdf_url":null,"pub_time":1582473600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"KTOV","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露報告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020004575/0001213900-20-004575-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020004575/f6k022420_kitovpharmaltd.htm","primary":true,"translateUrl":null,"linkName":"f6k022420_kitovpharmaltd.htm","type":"6-K","id":"NTFILE9T6TAMvMzSFFPvhq","market":"us","size":17985},{"description":"PRESS RELEASE","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020004575/f6k022420ex99-1_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"f6k022420ex99-1_kitovpharma.htm","type":"EX-99.1","id":"NTFILE6xJAdtMmcEw7BDA7","market":"us","size":16442}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露報告","pubTime":"2020-02-24 00:00","pubTimestamp":1582473600,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9088552","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020003507-KTOV","pdf_url":null,"pub_time":1581523200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Statement of acquisition of beneficial ownership by individuals","symbol":"KTOV","title":"Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020003507/0001213900-20-003507-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1609805/000121390020003507/sc13g0220pontifax_kitovpharm.htm","primary":true,"translateUrl":null,"linkName":"sc13g0220pontifax_kitovpharm.htm","type":"SC 13G","id":"NTFILE3eDCYTJedUGd9cRn","market":"us","size":162516}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2020-02-13 00:00","pubTimestamp":1581523200,"title_zh":"Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9075473","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020003232-KTOV","pdf_url":null,"pub_time":1581350400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"KTOV","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露報告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020003232/0001213900-20-003232-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020003232/f6k021020_kitovpharma.htm","primary":true,"translateUrl":null,"linkName":"f6k021020_kitovpharma.htm","type":"6-K","id":"NTFILE25fA34RvPMsd11R3","market":"us","size":18596},{"description":"PRESS RELEASE","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020003232/f6k021020ex99-1_kitovpharma.htm","primary":false,"translateUrl":null,"linkName":"f6k021020ex99-1_kitovpharma.htm","type":"EX-99.1","id":"NTFILE2NF2wPyJDqukyQp6","market":"us","size":162630}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露報告","pubTime":"2020-02-11 00:00","pubTimestamp":1581350400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9044471","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020002347-KTOV","pdf_url":null,"pub_time":1580659200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"KTOV","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露報告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020002347/0001213900-20-002347-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020002347/f6k020320_kitovpharmaltd.htm","primary":true,"translateUrl":null,"linkName":"f6k020320_kitovpharmaltd.htm","type":"6-K","id":"NTFILEDyMNPoMSgJhZqqmq","market":"us","size":15400},{"description":"PRESS RELEASE","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020002347/f6k020320ex99-1_kitov.htm","primary":false,"translateUrl":null,"linkName":"f6k020320ex99-1_kitov.htm","type":"EX-99.1","id":"NTFILEDb9ZsLvVXcqvuKZ5","market":"us","size":14612}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露報告","pubTime":"2020-02-03 00:00","pubTimestamp":1580659200,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9026655","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020001804-KTOV","pdf_url":null,"pub_time":1580054400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"KTOV","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"非美公司披露報告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020001804/0001213900-20-001804-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020001804/f6k012620_kitovpharma.htm","primary":true,"translateUrl":null,"linkName":"f6k012620_kitovpharma.htm","type":"6-K","id":"NTFILE5xDMkaEDZC3piACc","market":"us","size":11224},{"description":"PRESS RELEASE","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1614744/000121390020001804/f6k012620ex99-1_kitov.htm","primary":false,"translateUrl":null,"linkName":"f6k012620ex99-1_kitov.htm","type":"EX-99.1","id":"NTFILE4K7rkzM1xAmbFAxL","market":"us","size":11886}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"非美公司披露報告","pubTime":"2020-01-27 00:00","pubTimestamp":1580054400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8996349","market":"us","labels":[],"media":"sec.gov","original_id":"AN90266420000224-KTOV","pdf_url":null,"pub_time":1579017600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] Statement of acquisition of beneficial ownership by individuals","symbol":"KTOV","title":"[Amend] Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1614744/000090266420000224/0000902664-20-000224-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"[Amend] Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"KITOV PHARMA LTD.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1469336/000090266420000224/p20-0116sc13ga.htm","primary":true,"translateUrl":null,"linkName":"p20-0116sc13ga.htm","type":"SC 13G/A","id":"NTFILE4WxMr5ZCGsHH9F7W","market":"us","size":54855}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2020-01-15 00:00","pubTimestamp":1579017600,"title_zh":"Amend] Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":1,"totalSize":223,"code":"91000000","status":"200"}]}}